525 Results
Sort By:
Published on April 17, 2024
With the aim of bringing more real world data to cancer care, Flatiron Health and the National Comprehensive Cancer Network (NCCN) have renewed their collaboration to allow more cancer centers access to Flatiron’s curated data sets, and thus better evaluate and enhance the quality of care given at their sites.…
Published on August 7, 2023
Sponsored content brought to you by Real-world data (RWD) is enabling clinical trial research to better represent “real-world” scenarios and allowing the use of data beyond randomized clinical trials, including virtual patient cohorts. Generated by routine, patient standard-of-care, RWD captures information about comorbidities, disease complexity, patient paths, and outcomes…
Published on July 10, 2023
Thermo Fisher is acquiring CorEvitas, a provider of U.S. based regulatory-grade, real-world evidence for approved medical treatments and therapies, mainly for immune diseases, from Audax Private Equity for $912.5 million in cash. “The addition of CorEvitas will further advance our capabilities to better serve our pharma and biotech customers and…
Published on June 7, 2023
Findings by researchers from the University of Pennsylvania should reassure patients and clinicians that stopping immunotherapy for advanced non-small-cell lung cancer (NSCLC) after two years is not detrimental to survival when compared with continuing indefinitely. “Our study found that for patients who stopped immunotherapy at two years, their survival was…
Published on April 10, 2023
Sponsored content brought to you by A unique collaboration between BC Platforms and experts at the ASTAR’s Institute for Infocomm Research, Singapore (I2R), is raising ambitions in healthcare research among industry and academic partners. For the first time, homomorphic encryption (HE), applied to trusted collaboration environments, is providing enhanced data…
Published on February 10, 2023
One form of cheap and convenient RWD that is increasingly being collected comes from wearable devices such as smart watches, heart rate monitors, or continuous glucose monitors. Around 3.4 million people in the U.S. are diagnosed with epilepsy each year. Of these, around 30%, have uncontrolled epilepsy and struggle to…
Published on February 10, 2023
Results aren’t usually publicly shared, but behind the scenes, real-world data (RWD) and evidence (RWE) are having a big effect on rare disease drug development and clinical management. That impact is particularly evident in Duchenne Muscular Dystrophy (DMD) right now. Sarepta Therapeutics, for example, has three commercial DMD products already.…
Published on February 10, 2023
By Dan Rhodes, PhD, Co-Founder & CEO, Strata Oncology Sponsored content brought to you by At Strata Oncology, we won’t rest until every patient with cancer gets their best possible therapy. Our approach to achieving this audacious goal is to develop innovative, highly quantitative, DNA- and RNA-based multivariate predictive treatment…
Published on February 16, 2022
by Joseph Zabinski, PhD, Senior Director, AI & Precision Medicine, OM1 Sponsored content brought to you by Personalizing medicine using population-level insights can seem like a contradiction. On one hand, the goal is to better fit treatment to the individual patient, moving away from generalized approaches toward a “one…
Published on July 23, 2019
Precision cancer care company Syapse has announced it has entered a strategic alliance with pharmaceutical company Pfizer that will use real-world evidence to help advance research into effective cancer treatments and improve patient care. This newest deal is the third for Syapse engaging big pharma in a real-world data collaboration.…
Published on January 31, 2024
European cancer mortality predictions for 2024 highlight a concerning increase in colorectal cancer deaths among people aged 29–45 years that the researchers suggest is linked to increasing rates of overweight and obesity. For the 14th consecutive year, Carlo La Vecchia, professor of Medical Statistics and Epidemiology at the University of Milan…
Published on January 18, 2024
LunaDNA, once heralded as “the world’s first member-owned data-sharing platform for health research,” is to close on January 31, 2024. The San Diego company made the news official with a statement on its website. Earlier this month, the company had sent an email to customers with the headline “Luna is…
Published on December 22, 2023
Scientists at the Wellcome Sanger Institute, the University of Cambridge, and EMBL’s European Bioinformatics Institute (EMBL-EBI) have unveiled a transformative tool named CellHint. The methodology leverages machine learning to organize and categorize single-cell data, paving the way for the creation of harmonized datasets crucial for advancing the understanding of human…
Published on November 30, 2023
Entire genome sequences for nearly half a million people have been released by the UK Biobank, representing the largest dataset of its kind in the world. The resource has the potential to offer new insights into the causes of major common diseases and guide the choice of potential therapeutic targets.…
Published on October 18, 2023
Daniel Judge, MDDirector of the Cardiovascular Genetics Program and Fellowship Director for Cardiovascular DiseaseThe Medical University of South Carolina (MUSC) When Daniel Judge, MD, director of the Cardiovascular Genetics program and fellowship director for cardiovascular disease at The Medical University of South Carolina (MUSC), moved over…